The company said Monday that it’s received permission from the Food and Drug Administration to include adolescents aged 12 through 15 in its global COVID-19 vaccine study.
Until now, children under 16-years-old have not been included in any of the coronavirus vaccine trials underway in America.
Earlier this month, the group wrote to federal health officials urging them to include children in the trials.
“Children must be included in vaccine trials to best understand any potential unique immune responses and/or unique safety concerns,” the group wrote.
There are currently four coronavirus vaccine candidates in Phase 3/late-stage large-scale studies in the U.S.Back in early September, the CEO of Pfizer said he believed they should know by the end of October whether their vaccine is safe and effective.